论文部分内容阅读
Accepted by Oncotarget and will be published in January, 2017 Tomotherapy as an adjuvant treatment f
【作 者】
：
【机 构】
：
Department of Radiation Oncology, Cancer Hospital and Institute, National Cancer Center, Chinese Aca
【出 处】
：
2016年北京市肿瘤放疗年会
【发表日期】
：
2016年5期
其他文献
Screening the High-risk Population of Breast Cancer Brain Metastasis Accompanied with Severe Peritum
Objective:To determine the high-risk population of breast cancer brain metastasis accompanied with severe peritumoral brain edema, and to probe into the effects of peritumoral brain edema degree on th
会议
Previous studies have investigated the prognostic significance of B7 homolog 3 (B7-H3) in non-small cell lung cancer (NSCLC), however, the results remain controversial.This study was aimed to determin
The outcome of recurrent brain metastasis is dismal.This study aims to assess the clinical outcomes and toxicity of reirradiation as a salvage treatment for progressive brain metastasis in patients wi
Targeted therapy and radiotherapyfor brain metastases in non-small lung cancer patients: When is the
The clinical outcomes of the sequential versus concurrenttherapy of targeted therapy andradiotherapy are still unconfirmedin patients with brain metastases (BM).To evaluate the role ofthe combination
Purpose: Brain metastasis (BM) with a cystic component from breast cancer is rare and largely uncharacterized.The purpose of this study was to identify the characteristics of cystic BM in a large coho
Out-of-field tumor response, which is also called abscopal effect, bystander effect, or non-target effect, can be regarded as localized irradiation induced systemic antitumorigenic effects, indicating
患者肺癌晚期行多程化疗后复发，纵隔及锁骨上淋巴结引流区曾行根治性放疗。目前肺内多发转移。此次改行射波刀治疗，应用金标植入的方式进行追踪呼吸运动，最大可能的减少了正常肺组织的受照射体积。术后随诊发现该患者照射靶区病灶得到良好控制的同时发生远隔效应，靶区外两处转移病灶减小及消失。究其原因可能与射波刀的剂量分割模式相关。本文所报道患者在肺内病灶射波刀治疗3个月后复查发生远隔效应，行健择单药维持化疗，3个
Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive
Purpose: The role of adjuvant chemoradiotherapy (ACRT) or adjuvant chemotherapy (ACT) in treating patients with locally advanced upper rectal cancer (URC) after total mesorectal excision (TME) surgery